OOIR: Observatory of International Research

Papers

(The H4-Index of BMC Cancer is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Favorable locoregional control in clinically node-negative hormone-receptor positive breast cancer with low 21-gene recurrence scores: a single-institution study with 10-year follow-up	273
The change rate in serum nitric oxide may affect lenvatinib therapy in hepatocellular carcinoma	159
Increased use of diagnostic CT imaging increases the detection of stage IA lung cancer: pathways and patient characteristics	143
Lnc-SELPLG-2:1 enhanced osteosarcoma oncogenesis via hsa-miR-10a-5p and the BTRC cascade	128
Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma—randomized phase 2 trial ARION UCGI 33/PRODIGE 67: the study protocol	109
Chemotherapy dose per kilogram lean body mass increased dose-limiting toxicity event in male head and neck cancer with taxane and platinum-based induction therapy	89
Exploring optimal administration timing of pegylated recombinant human granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in early breast cancer treated with pharmorubicin and	75
ESR1 PvuII polymorphism: from risk factor to prognostic and predictive factor of the success of primary systemic therapy in advanced breast cancer	70
Network Evolution Model-based prediction of tumor mutation burden from radiomic-clinical features in endometrial cancers	69
Results from a real-world study: a novel glycosyltransferase risk score for prognosis, tumor microenvironment phenotypes and immunotherapy in bladder cancer	68
Adult breast, lung, pancreatic, upper and lower gastrointestinal cancer patients with hospitalized venous thromboembolism in the national French hospital discharge database	68
Novel model integrating computed tomography-based image markers with genetic markers for discriminating radiation pneumonitis in patients with unresectable stage III non-small cell lung cancer receivi	66
Oral cavity and oropharyngeal carcinoma disparities in age and survival in Indigenous and non-Indigenous populations of Queensland	64
Association of HLA-A*02:01 type with efficacy and toxicity of immune checkpoint inhibitor therapy in melanoma patients: a retrospective cohort study	63
Clinical benefits of enhanced 3D-NEVERview sequence in MRI simulation for nasopharyngeal carcinoma patients received radiotherapy	61
High SNHG expression may predict a poor lung cancer prognosis based on a meta-analysis	59
Pseudocapsule thickness is positively associated with prognosis in patients with clear cell renal cell carcinoma	57
Association of portfolio diet score with breast cancer risk: insights from a case-control analysis	56
Understanding referral of patients with cancer in rural Ethiopia: a qualitative study	55
Azacytidine treatment affects the methylation pattern of genomic and cell-free DNA in uveal melanoma cell lines	55
Unraveling the causal links and novel molecular classification of Crohn’s disease in breast Cancer: a two-sample mendelian randomization and transcriptome analysis with prognostic modeling	54
The mortality rate of people with cancer judged to have a limited life expectancy by physicians performing work disability assessments in the Netherlands: a retrospective cohort study	54
Realizing the promise of machine learning in precision oncology: expert perspectives on opportunities and challenges	54
Gross recurrent laryngeal nerve invasion by extranodal extension in thyroid carcinoma	54
Neoadjuvant immune checkpoint inhibitor reduced recurrence in operable NSCLC patients with pathological complete response: a retrospective analysis	52

Prospective clinical evidence from over 1,000 pan-cancer patients: a complement to fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting	51
Construction and validation of a gene signature related to bladder urothelial carcinoma based on immune gene analysis	50
Antibiotic use during radical surgery in stage I-III colorectal cancer: correlation with outcomes?	49
Tertiary lymphoid structures associate with improved survival in early oral tongue cancer	48
Survival impact and risk factors of skeletal muscle loss during first-line EGFR-TKIs therapy in advanced lung adenocarcinoma patients	48
Analysis of characteristics of peripheral blood lymphocytes in endometrial carcinoma: a single-center study based on five-year clinical data	48
Factors influencing clinical decision-making and health-related quality of life changes in colorectal cancer patients receiving targeted therapy: a multicenter study in China	47
Mismatch repair, p53, and L1 cell adhesion molecule status influence the response to chemotherapy in advanced and recurrent endometrial cancer	46
Associations of the circulating levels of cytokines with the risk of myeloproliferative neoplasms: a bidirectional mendelian-randomization study	45
Prognostic value of IDH2R140 and IDH2R172 mutations in patients with acute myeloid leukemia: a systematic review and meta-analysis	45
Single-copy Snail upregulation causes partial epithelial-mesenchymal transition in colon cancer cells	45
Alpha-1 antitrypsin deficiency and risk of lung cancer in never-smokers: a multicentre case–control study	44
Rationale and design of APOLLO: a personalized rehAbilitation PrOgram in aLLOgeneic bone marrow transplantation	44
Exploring the role of ELOVLs family in lung adenocarcinoma based on bioinformatic analysis and experimental validation	44
The efficacy of human epidermal growth factor receptor 2 (HER2) blockade switching mode in refractory patients with HER2-positive metastatic breast cancer: a phase II, multicenter, single-arm study (S	43
MTF1 genetic variants are associated with lung cancer risk in the Chinese Han population	43
Exercise-based dysphagia rehabilitation for adults with oesophageal cancer: a systematic review	43
Camrelizumab combined with apatinib plus irinotecan as a second-line treatment in advanced or metastatic esophageal squamous cell carcinoma patients	42
Integrative analysis of the prognostic value and immune microenvironment of mitophagy-related signature for multiple myeloma	42
Effects of neoadjuvant radiochemotherapy for anorectal function in locally advanced rectal cancer patients: a study protocol for a prospective, observational, controlled, multicentre study	42